Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Vaccines Market Size To Reach USD 153.49 Billion, With at a 14.1% CAGR between 2022 to 2028 | Brandessence Market Research

      BEMR Logo (PRNewsfoto/Brandessence Market Research And Consulting Private Limited)

      News provided by

      Brandessence Market Research And Consulting Private Limited

      Sep 26, 2023, 02:45 ET

      Share this article

      Share this article


      LONDON, Sept. 26, 2023 /PRNewswire/ -- According to a comprehensive research report by Brandessence Market Research (BMRC), "Vaccines Market Size, Share, Companies & Trends Analysis Report By Technology, By Indication, By End User, Based On Region, And Segment Forecasts, 2022-2028". The Vaccines Market was valued at USD 56.98 billion in 2021 and expected to reach USD 153.49 billion By 2028, amplifying with a CAGR of 14.1% over 2022-2028.

      Market Overview:

      In a world that has been irrevocably altered by the COVID-19 pandemic, the vaccines market has come into sharper focus than ever before. With the race to develop effective vaccines against the virus, the industry has witnessed unprecedented growth and innovation. However, the vaccines industry is not limited to just one virus; it encompasses a wide range of vaccines designed to combat various diseases. In this article, we will delve into the market, exploring its scope, segmentation, market dynamics, and its promising outlook.

      Scope of the Vaccines Market:

      Report Metric

      Details

      Vaccines Market Revenue forecast in 2028

      USD 153.49 billion

      Market Size in 2021

      USD 56.98 billion

      Market Growth Rate

      CAGR of 14.1% from 2022 to 2028

      Base Year

      2021

      Study Period

      2022-2028

      Key Players/Companies

      Glaxo Smith Kline plc, Pfizer Inc., Merck & Co. Inc., Sanofi, CSL Limited, Emergent BioSolutions Inc., Johnson & Johnson, Medimmune LLC, AstellasPharma Inc., Serum Institute of India, Bavarian Nordic, Mitsubishi Tanabe Pharma Corporation, Daiichi Sankyo Company Limited, Panacea Biotech, Protein Sciences Corporation, AstraZeneca, Abbott, Bristol-Myers Squibb, Novavax Inc., Gritstone Oncology, PaxVax Corporation., Bharat Biotech., VBI Vaccines Inc., Dynavax Technologies Corporation, Immunomic Therapeutics Inc., Gamma Vaccines Pty Limited, Sinovac Biotech Ltd., Janssen Pharmaceutical Company, Takeda Pharmaceuticals Company Ltd., Valeant Pharmaceuticals International Inc., China National Biotech, Tiantan, Hualan, Kangtai, Prokarium, ImmunoBiology Ltd.

      The scope of the vaccines market is vast, covering a plethora of infectious diseases and preventive measures. Vaccines are biological products that stimulate the immune system to produce an immune response against specific pathogens. This market extends its reach to vaccines targeting diseases such as influenza, hepatitis, polio, measles, mumps, rubella, and more. Additionally, the recent surge in vaccine development for emerging diseases like COVID-19 has showcased the industry's capacity for rapid response.

      Moreover, the vaccines market has witnessed an expansion into therapeutic vaccines, which hold the potential to treat diseases like cancer and autoimmune disorders. The market's scope, therefore, is not just limited to prevention but also includes treatment, making it a crucial segment of the pharmaceutical and healthcare sectors.

      Get Free Sample PDF Brochure:

      https://brandessenceresearch.com/downloadSample/PostId/276

      Segmentation of the Vaccines Market:

      The market can be segmented in various ways to provide a comprehensive view of its dynamics. Here are some key segments:

      1. Type of Vaccine:

      • Inactivated Vaccines: These contain killed pathogens or portions of them, incapable of causing disease.
      • Live Attenuated Vaccines: These contain weakened forms of the pathogen, which can still induce an immune response without causing the disease.
      • Subunit, Recombinant, or Conjugate Vaccines: These vaccines contain only specific antigens or proteins from the pathogen.
      • mRNA Vaccines: A more recent addition, these vaccines use genetic material to trigger an immune response.

      2. Disease Indication:

      • Infectious Diseases: This includes vaccines against viral and bacterial infections.
      • Non-Infectious Diseases: This encompasses therapeutic vaccines against cancer, allergies, and autoimmune disorders.

      3. Age Group:

      • Pediatric Vaccines: Designed for infants and children to protect against childhood diseases.
      • Adult Vaccines: Targeting diseases such as influenza, shingles, and HPV in adults.

      4. Region:

      • North America, Europe, Asia-Pacific, and Rest of the World: Each region has its own vaccine market dynamics influenced by factors like disease prevalence, healthcare infrastructure, and government policies.

      Browse In-depth Market Research Report (300 Pages) on Vaccines Market:

      https://brandessenceresearch.com/healthcare/vaccines-market-by-technology

      Competitive Hierarchy:

      The prominent players Vaccines Market Outlook are-

      • Glaxo Smith Kline plc
      • Pfizer Inc.
      • Merck & Co. Inc.
      • Sanofi
      • CSL Limited
      • Emergent BioSolutions Inc.
      • Johnson & Johnson
      • Medimmune LLC
      • AstellasPharma Inc.
      • Serum Institute of India
      • Bavarian Nordic
      • Mitsubishi Tanabe Pharma Corporation
      • Daiichi Sankyo Company Limited
      • Panacea Biotech
      • Protein Sciences Corporation
      • AstraZeneca
      • Abbott
      • Bristol-Myers Squibb
      • Novavax Inc.
      • Gritstone Oncology
      • PaxVax Corporation.
      • Bharat Biotech.
      • Others.

      Market Dynamics:

      1. Growing Awareness and Immunization Campaigns

      The global awareness of the importance of vaccination has surged, driven by educational campaigns and increasing access to information. Governments and healthcare organizations worldwide are running immunization programs to reach underserved populations, contributing to market growth.

      2. Expanding Investment in Research and Development

      The COVID-19 pandemic has highlighted the need for rapid vaccine development. This has led to increased investment in research and development, fostering innovation in vaccine technology.

      3. Rising Disease Burden

      As global populations grow and age, the burden of infectious and non-infectious diseases is on the rise. This necessitates the development of new and improved vaccines.

      4. Regulatory Support and Stringent Quality Control

      Governments and regulatory bodies play a pivotal role in ensuring vaccine safety and efficacy. Stringent quality control measures are in place to maintain public trust.

      Purchase Copy of This Research Report @:

      https://brandessenceresearch.com/Checkout?report_id=276

      Vaccines Market Outlook:

      The future of the vaccines market is bright. It is expected to continue its growth trajectory due to ongoing research and development efforts, increased disease awareness, and government support. The global vaccine market is also likely to benefit from advancements in vaccine technology, including mRNA vaccines and personalized vaccines tailored to individual genetic profiles.

      Additionally, the lessons learned from the rapid development of COVID-19 vaccines have paved the way for a more agile and responsive industry, better prepared to tackle emerging threats. With a broader range of preventive and therapeutic vaccines on the horizon, the market is poised to play a pivotal role in shaping the future of healthcare.

      Conclusion:

      The vaccines market is not just about preventing diseases; it is about safeguarding public health and driving innovation in healthcare. As we navigate the challenges of an ever-evolving healthcare landscape, the vaccines market will remain at the forefront, offering hope, protection, and a brighter future for humanity.

      Related Reports:

      Demodex Blepharitis: How to Achieve Eye Health and Eliminate Demodex

      Navigating Solid Tumor Diseases: Insights and Consulting Services

      Unveiling Hope: Navigating Duchenne Muscular Dystrophy (DMD)

      Unlocking Relief: Effective Psoriasis Disease Management Strategies

      Unlocking the Latest Breakthroughs in Alzheimer's Disease Research: Hope on the Horizon

      Rising Against the Odds: Global Insights into Multiple System Atrophy (MSA) Disease

      Case study on the Development of Innovative Medicine

      Case Study: Software Application for Personalized Care with Data-Driven Insights

      Case Study: Cancer Vaccine with Specific Antigens

      Combination Trials for Lung Cancer Immunotherapy - Case Study

      Using software to manage the supply chain and the inventory

      Asset Scouting for Cystic Fibrosis: A Case Study

      A Revolutionary Non-Invasive Glucose Monitoring Device Receives Regulatory Approval and Effective Commercialization

      Investment in Pancreatic Cancer Chemotherapy

      Predictive Analytics Powered by AI: Unlocking Insights for the Future of Healthcare

      Natural Language Processing (NLP) in Healthcare: Unlocking the Potential

      Posluma: A Targeted Oncology Breakthrough in Prostate Cancer Imaging

      Fezolinetant by Veozah: Advancing Women's Health by Astellas Pharma Inc.

      A Hopeful Sign for Migraine Sufferers: Zavzpret

      Rethinking Treatment Options for a Better Future with Hemophilia Gene Therapy

      About Us:

      Brandessence Market Research & Consulting Pvt ltd.

      Brandessence Market Research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London.

      Follow Us: LinkedIn  

      Contact:

      Mr. Vishal Sawant 
      Email: [email protected]
      Email: [email protected] 
      Corporate Sales: +44-2038074155 
      Asia Office: +917447409162

      Logo: https://mma.prnewswire.com/media/1392316/BEMR_Logo.jpg

      SOURCE Brandessence Market Research And Consulting Private Limited

      Modal title

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.